Objective: Prolonged cardiac contraction and relaxation in hypothyroidism are in part related to diminished expression of the gene coding for the calcium pump of the sarcoplasmic reticulum (SERCA2a). Therefore, we examined whether or not transgenic SERCA2a gene expression in mice may compensate for the cardiac effects of hypothyroidism. Methods: SERCA2a mRNA and protein were analyzed from hearts of euthyroid and hypothyroid mice of wild-type or SERCA2a transgene status. Contractile function was studied in isolated left ventricular papillary muscles. Results: We found significant decreases of SERCA2a mRNA and protein levels in hearts of hypothyroid wild-type mice in comparison with euthyroid wild-type mice (controls). Papillary muscles from hypothyroid wild-type mice showed significant increases in time to peak contraction and relaxation times compared with controls. In contrast, SERCA2a mRNA and protein levels were significantly higher in hypothyroid SERCA2a transgenic mice than in hypothyroid wild-type mice. The transgene led to a functional improvement by compensating for the prolonged contraction and relaxation of papillary muscles. Conclusions: Our murine model of hypothyroidism revealed decreases in SERCA2a gene expression accompanied by prolonged contraction and relaxation of papillary muscles, and an improvement of the contractile phenotype due to compensated SERCA2a gene expression in SERCA2a transgenic mice.
Introduction
We recently reported increased SERCA2a mRNA and protein levels in a transgenic mouse line overexpressing 21 The calcium pump, or Ca -ATPase, of the sarcoplasSERCA2a [5] . Functionally, the mice showed enhanced mic reticulum (SERCA2a) is a major regulator of cardiac relaxation of isolated cardiac myocytes, papillary muscles, 21 contractile function. During cardiac relaxation, Ca upand the in vivo heart, as well as accelerated calcium take into the sarcoplasmic reticulum (SR) accounts for the transients. Since these mice express a functionally active 21 majority of Ca removal from the cytoplasm. SERCA2a SERCA2a transgene that results in contractile alterations, activity is therefore the most important determinant of the we were interested in exploring its implications in speed of cardiac relaxation. SERCA2a activity also affects pathophysiologic conditions with downregulated the magnitude and rate of force development during SERCA2a. 21 cardiac contractions by altering the SR's Ca content.
In this report, we examined a potential compensatory Decreases in SERCA2a protein levels or its activity function of SERCA2a transgene expression in hypothyroidism [6] . Prolonged cardiac contraction and relaxation are prominent features of hypothyroidism in several species, including the mouse [7] . In addition to changes in ized to the average of all control lanes (wild-type, myosin isoforms [8, 9] , decreases in SERCA2a mRNA [10] euthyroid). and protein levels [1] have been reported in hypothyroid rats. We postulated that decreased SERCA2a expression 2.3. Western blot analysis contributes to the impaired relaxation in hypothyroid mice, and that prolonged cardiac contraction and relaxation can
Proteins from ventricular homogenates (n53 in each be improved or compensated by SERCA2a transgene group) were resolved by gel electrophoresis and transexpression in transgenic mice.
ferred onto nitrocellulose membranes with a Novex transTo examine these hypotheses, wild-type and SERCA2a fer apparatus (San Diego, CA, USA). A rabbit polyclonal transgenic mice were made hypothyroid and compared antibody against rat SERCA2 was used as previously with euthyroid wild-type and SERCA2a transgenic mice.
described [14] . Secondary antibody labeling and protein Contractile function was studied in isolated left ventricular detection were performed with an ECL Western blotting kit papillary muscles, as recently described [5] . In light of the by Amersham (Little Chalfont, UK). Western blots were prevalence of genetically engineered mice, this technique scanned and normalized to the average of all control lanes should be of major interest for characterizing murine (wild-type, euthyroid). cardiac contractile phenotypes. The papillary muscle preparation is particularly suitable for resolving changes in the 2.4. Hypothyroidism time courses of contraction and relaxation, which are the predominant cardiac manifestations of hypothyroidism.
Mice were made hypothyroid by the addition of 0.15% Our results prove in principle the feasibility of a transgene-5-propyl-2-thiouracil (PTU) to their food for four weeks or 131 mediated compensation for a loss of endogenous gene by injection of radioactive iodine (100 mCi of Na I, i.p.) expression and a resulting recovery of contractile function.
four weeks prior to sacrifice. Blood obtained by cardiac puncture or from the chest following removal of the heart was collected into Eppendorf tubes containing 10 USP units of heparin. Serum was obtained by centrifugation at 2. Methods 48C and stored at 2208C for later analysis. Total serum levels of the thyroid hormone thyroxine (T ) were de- Left ventricular mouse papillary muscles were isolated SERCA2a heterozygous transgenic mice were conas follows from 14 euthyroid wild-type, 14 euthyroid structed as previously described [5] , using standard techtransgenic, six hypothyroid wild-type, and five hyponiques [11] . Transgene expression of a rat SERCA2a thyroid transgenic mice. The mice were deeply anescDNA was driven by a human cytomegalovirus (CMV) thetized with ketamine (140 mg / kg i.p.) and xylazine (10 immediate early enhancer and a chicken b-actin promoter.
mg / kg i.p.). Hearts were removed and rinsed in oxyTo identify transgene-positive animals, tail clips were genated Tyrode solution (in mM: 136 NaCl, 5.4 KCl, 1 taken from the mice at three weeks of age. DNA was then MgCl , 0.33 NaH PO , 10 N-2-hydroxyethylpiperazine-
isolated and screened by polymerase chain reaction (PCR) N9-2-ethanesulfonic acid (HEPES), 10 glucose, 2.5 CaCl , 2 using primers internal to the human CMV enhancer of the pH 7.40) containing 30 mM 2,3-butanedione monoxime transgene. This reaction yields an amplified fragment of (BDM). Left ventricular papillary muscles were excised, 300 bp in the transgenic animals.
inserted into V-shaped clamps made from strips of platinum foil, and tied with 6.0 braided silk suture. The 2.2. Northern blot analysis muscles were transferred to a 0.5-ml muscle chamber where they were mounted on hooks of platinum wire. RNA was isolated from ventricular homogenates (n56-Muscles were perfused with Tyrode solution at 378C and 7 in each group) as described by Chomczynski and Sacchi stimulated at 2 and 6 Hz stimulation frequencies through [12] . Standard protocols were used for gel electrophoresis, the platinum clamps (5 V, 0.1 ms duration). Force was Northern transfer and hybridization [13] . Membranes were measured with an isometric force transducer (model probed with a 1.8-kb EcoRI restriction fragment corre-OPT1L, Scientific Instruments, Heidelberg, Germany) and sponding to the 59-end of the rat SERCA2a cDNA. We recorded on a strip chart recorder. Muscles were stretched further probed for myosin heavy chain b, and for 28S as a over a period of 30 to 60 min to the length at which active loading standard. Northern blots were scanned and normalforce development was maximal (L determined as the time from the peak of contraction to 50 or 90% of tension decline (50 or 10% of remaining tension) during relaxation. gene-induced accelerations of contraction and relaxation were determined by comparing results from wild-type and in transgenic euthyroid mice compared with wild-type transgenic hypothyroid mice. Compensation was calculated euthyroid mice (P,0.05). Hypothyroidism decreased as the ratio of transgene-induced acceleration to hypoSERCA2a mRNA by 36% in wild-type mice (P,0.05). thyroidism-induced delay (Table 1) .
Quantification of compensation
However, in SERCA2a transgenic animals, hypothyroidism decreased SERCA2a mRNA only by 25% (euthyroid 2.7. Statistical analysis transgenic vs. hypothyroid transgenic, P,0.05), and there was no significant difference between SERCA2a mRNA Statistical analysis was performed by analysis of varilevels of hypothyroid transgenic and euthyroid wild-type ance (ANOVA). Twitch parameters were analyzed with mice. Expression of the SERCA2a transgene compensated repeated measures ANOVA with combined data from 2 therefore for the loss of endogenous SERCA2a gene and 6 Hz stimulation frequencies. Northern and Western expression with hypothyroidism. blot data were analyzed by one-factor ANOVA. Post-hoc Western blot analysis was used to compare SERCA2a comparisons between multiple groups were performed in protein expression from wild-type mice and from hypoeach case by a Student-Newman-Keuls test. Data are thyroid transgenic mice (Fig. 3 ). We observed a 26% presented as mean6standard error. Statistical significance reduction in SERCA2a protein expression with hypowas assumed for P,0.05. thyroidism in wild-type mice (P,0.05). However, this was partially compensated for in hypothyroid transgenic mice, where SERCA2a protein levels were reduced by only 18% 3. Results (P,0.05).
Gene expression 3.2. Papillary muscle experiments
In order to examine the effects of hypothyroidism on the Contractile function was measured in papillary muscles expression of SERCA2a and myosin heavy chain b in wild-type and SERCA2a transgenic animals, we used Northern blot analysis to determine the respective levels of mRNA from seven euthyroid wild-type, six euthyroid transgenic, seven hypothyroid wild-type and seven hypothyroid transgenic mice. Serum T levels ranged from 0 to 4 0.6 ng / dL in hypothyroid mice and from 2.7 to 5.0 ng / dL in euthyroid mice. Representative Northern blots are shown in Fig. 1 . Myosin heavy chain b expression was absent in euthyroid mice, but strongly induced in both wild-type and transgenic mice that were made hypothyroid. SERCA2a expression was decreased by hypothyroidism and increased by SERCA2a transgene expres- from wild-type mice and from mice expressing a restored the speed of contraction of hypothyroid mice. SERCA2a transgene. In our earlier study [5] , we showed However, this compensation was only partial, since time to that overexpression of SERCA2a resulted in accelerated peak tension of muscles from hypothyroid transgenic mice relaxation in vivo, in papillary muscles and isolated was still significantly increased compared with that of myocytes, and in an accelerated decline of intracellular euthyroid controls. calcium transients. Here, we analyzed the effects of
We measured the relaxation time, RT , of isolated 50 hypothyroidism on contractile function in wild-type and papillary muscles to determine the effects of altered SERCA2a transgenic mice.
SERCA2a expression on cardiac relaxation in hypothyroidSix wild-type mice and six SERCA2a transgenic mice ism of wild-type and SERCA2a transgenic mice (Fig. 5 ). were injected with radioactive iodine. At four weeks following injection, one transgenic mouse had a normal serum T level (2.9 ng / dL) and was hence excluded from 4 the analysis. The other eleven mice became markedly hypothyroid, with serum T levels ranging from 0.1 to 0.7 4 ng / dL. Fourteen euthyroid wild-type mice and fourteen euthyroid SERCA2a transgenic mice were used for comparison, with serum T levels ranging from 2.5 to 6.5 4 ng / dL. The papillary muscles isolated from the 39 mice had a length of 2.0460.08 mm and a cross-sectional area 2 of 0.4060.03 mm , with no significant differences between groups.
We measured the time to peak tension of left ventricular papillary muscles to determine the effects of SERCA2a transgene expression and of hypothyroidism on the time course of active force development (Fig. 4) . In papillary muscles from euthyroid mice, time to peak tension was wild-type mice had significantly increased relaxation times, RT , compared with those of euthyroid wild-type 50 mice. However, this delay in relaxation was compensated for in hypothyroid transgenic mice, and RT in this group contraction (time to peak tension) was only partially 50 was not significantly different from the RT of muscles compensated for. 50 from euthyroid wild-type mice. We further measured the relaxation time, RT (to 90% 90 of tension decline), which includes also the late phase of 4. Discussion relaxation (Fig. 6) . The changes in RT were qualitatively 90 similar to the changes in RT : a significant acceleration of Prolonged cardiac contraction and relaxation are promi-50 relaxation with transgene expression in both euthyroid and nent manifestations of hypothyroidism. These prolongahypothyroid mice, and a significant delay in hypothyroid tions are mediated in part through decreased sarcoplasmic 21 mice compared with euthyroid mice. The relaxation times, reticulum Ca -ATPase (SERCA2a) expression. The mu-RT , of muscles from hypothyroid transgenic mice were rine model of hypothyroidism presented in this study 90 not significantly different from those of euthyroid wildreveals decreased SERCA2a mRNA levels as well as type mice.
prolonged cardiac contraction and relaxation of isolated The functional compensation of SERCA2a transgene papillary muscles from wild-type mouse. However, when expression in hypothyroidism is quantified and summatransgenic mice overexpressing SERCA2a were made rized in Table 1 . While the impaired relaxation was mostly hypothyroid, SERCA2a mRNA was not different from that (RT ) or fully (RT ) compensated for, the prolonged of wild-type euthyroid mice. Contraction and relaxation 50 90 mice. 'Acceleration with transgene' compares hypothyroid wild-type mice with hypothyroid transgenic mice. 'Compensation' was determined by the ratio of the acceleration to the prolongation. RT , relaxation time to 90% of tension decline. TPT, time to peak tension.
were faster in hypothyroid transgenic mice than in hypohypothyroidism with SERCA2a transgene expression thyroid wild-type mice, i.e., SERCA2a overexpression points to potential therapeutic benefits of SERCA2a transaccelerated the prolonged time courses normally observed gene expression. However, due to the transgenic animal in hypothyroidism. Therefore, our results provide a promapproach used in this study, transgene expression was ising example of a transgene-mediated functional improvealready present prior to the onset of hypothyroidism. As a ment of a pathophysiologic cardiac condition.
result, there were already small differences in relaxation Prolonged cardiac contraction and relaxation with hypotime in the euthyroid animals. However, these differences thyroidism have been shown in several species, including were larger in the hypothyroid animals. Furthermore, there the mouse [7] . Induction of myosin heavy chain b has been was no difference in time to peak tension in the euthyroid identified as a contributing factor in both the rat [9] and the animals, but the transgene corrected for about half of the mouse [8] . In addition, decreases in SERCA2a mRNA [10] considerable prolongation in contraction in the hypothyroid and protein [1] have been shown in the rat. We have shown animals. These considerations underline that our results in this study that a decrease in SERCA2a mRNA concurs indicate indeed a compensatory function of the transgene with prolonged contraction and relaxation in papillary under hypothyroid conditions rather than merely a similar, muscles from hypothyroid mice.
and perhaps expected, phenotype in both euthyroid and Induction of myosin heavy chain b and reduction of hypothyroid animals. endogenous SERCA2a are not expected to contribute A definitive 'rescue' of a hypothyroid phenotype could equally to the delays in contraction and relaxation obonly be documented by an actual gene therapy approach served in hypothyroidism. SERCA2a overexpression, for consisting of a transgene-induced correction of impaired example, did not alter the time to peak tension in euthyroid function following the onset of hypothyroidism. Currently, mice but affected primarily the speed of relaxation. On the these techniques are not readily available in the mouse, but other hand, changes in myosin isoforms have marked advances in gene delivery to the heart or improved effects on the speed of contraction. Nevertheless, contracmethods of conditional transgene expression may soon tion and relaxation and their underlying molecular mechaoffer additional avenues. nisms are not entirely independent of each other. In Genetically engineered animals offer exciting opporcontrast to the euthyroid animals, overexpression of tunities for studying the molecular mechanisms of SERCA2a did accelerate the prolonged tension developpathophysiologic conditions and for exploring possible ment of hypothyroid mice, possibly through increased SR gene therapy approaches to cardiovascular diseases 21 21 Ca loading and accelerated release of Ca from the SR.
[17,18]. The prevalence of genetically altered mice has The fact that this compensation of time to peak tension motivated the development of experimental techniques for was incomplete is consistent with the assumption that characterizing the murine cardiac phenotype. Despite the myosin isoforms are an important determinant of the speed undisputed importance of in vivo measurements [19] [20] [21] of contraction. On the other hand, SERCA2a is the most for characterizing integrated physiological responses, much important regulator of the speed of relaxation. Therefore, insight into fundamental mechanisms may be obtained the more complete compensation of relaxation times is from in vitro methods ranging from the isolated cardiac consistent with the full compensation of SERCA2a gene myocyte [22, 23] to the isolated working heart [7] . expression, as revealed by Northern blot analysis.
Isolated cardiac muscle preparations such as papillary The effects of hypothyroidism and of SERCA2a transmuscles or trabeculae have greatly contributed to our gene expression were not related to developmental changes understanding of cardiac physiology in many species. In or changes in other genes related to calcium handling the mouse, however, there are only a very limited number (except for myosin heavy chain b). Animals were at least of reports from isolated left atrial [24] , right ventricular two to three months old at the onset of hypothyroidism.
[25] or left ventricular [26] preparations. In a recently SERCA2a transgene expression is sustained throughout the published study [5] , we examined for the first time the life span of the animals. In earlier studies, the contractile contractile function of isolated left ventricular papillary phenotype of SERCA2a transgenic mice was unchanged muscles from a transgenic mouse and found enhanced with age for mice between two and eleven months of age relaxation in muscles overexpressing the sarcoplasmic 21 (data not shown). In our previous study that characterized reticulum Ca -ATPase (SERCA2a). In this report, we the SERCA2a transgenic mice [5] , we found no changes in have applied this model to the study of the cardiac mRNA levels of ryanodine and calsequestrin and no manifestations of hypothyroidism [6] . The technique significant changes in protein levels of phospholamban and should be of further interest to other investigators for 1 21 the Na / Ca -exchanger. Furthermore, two recent studies characterizing cardiac contractile phenotypes in the mouse, that investigated protein levels of calsequestrin, phosespecially when time courses of contraction and relaxation pholamban, actin and tropomyosin in mice overexpressing or frequency-dependent behaviors are of primary interest. 
